Uzma Sarwar
Pfizer (United States)(US)
Publications by Year
Research Areas
Respiratory viral infections research, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Mosquito-borne diseases and control, Influenza Virus Research Studies
Most-Cited Works
- → Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine(2013)772 cited
- → Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age(2021)616 cited
- → Protection against malaria at 1 year and immune correlates following PfSPZ vaccination(2016)374 cited
- → Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial(2014)248 cited
- → Quantitative Phosphoproteomics Dissection of Seven-transmembrane Receptor Signaling Using Full and Biased Agonists(2010)147 cited
- → Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial(2014)131 cited
- → Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age(2023)98 cited
- → Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses(2017)71 cited
- → Comparison of adaptive and innate immune responses induced by licensed vaccines for human papillomavirus(2014)71 cited
- → Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial(2025)69 cited